1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Refractory Chronic Cough: new trials by email Literature Review of Refractory Chronic Cough trials Research Report on Refractory Chronic Cough
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough BLU-5937, Placebo - Cough, Refractory Chronic Cough | Phase 3 | Active not recruiting | Bellus Health Inc. - a GSK company | 997 | 2022-12-05 | 2026-07-14 |
Chronic Cough (1) · Cough (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Signs and Symptoms, Respiratory (1)
Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
BLU-5937 (1)
Bellus Health Inc. - a GSK company (1)
Australia (1) · Canada (1) · China (1) · Czechia (1) · Germany (1) · India (1) · Japan (1) · New Zealand (1) · Slovakia (1) · South Korea (1) · Taiwan (1) · United Kingdom (1) · United States (1)